Sort   by:  
 Page size 
Loss of Spindly sensitizes EML4-ALK v3 lung cancer cells to HSP90 inhibitors
Heat Shock Protein 90 inhibitors (HSP90i) have shown encouraging activity in EML4-ALK+ non-small cell lung cancer (NSCLC) patients but clinical responses have been heterogeneous. It has been suggested that distinct EML4-ALK variants may have a differential impact on the response to HSP90 inhibition....
ORGANISM(S): Homo sapiens 
2025-02-01 | GSE197655 | GEO
Sort   by:  
 Page size